Cohen Klingenstein’s AbbVie ABBV Stock Holding History

Cohen Klingenstein’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.71M	Hold	18,000	–	–	0.13%	73
2026 Q2	$4.53M	Hold	18,000	–	–	0.13%	75
2026 Q1	$3.91M	Hold	18,000	–	–	0.13%	81
2025 Q4	$4.11M	Hold	18,000	–	–	0.13%	76
2025 Q3	$4.17M	Hold	18,000	–	–	0.13%	75
2025 Q2	$3.34M	Hold	18,000	–	–	0.11%	86
2025 Q1	$3.77M	Hold	18,000	–	–	0.14%	79
2024 Q4	$3.2M	Sell	18,000 -32,500	-64%	-$5.98M	0.11%	87
2024 Q3	$10M	Hold	50,500	–	–	0.35%	49
2024 Q2	$8.66M	Hold	50,500	–	–	0.31%	51
2024 Q1	$9.2M	Hold	50,500	–	–	0.34%	48
2023 Q4	$7.83M	Hold	50,500	–	–	0.32%	51
2023 Q3	$7.53M	Hold	50,500	–	–	0.34%	51
2023 Q2	$6.8M	Hold	50,500	–	–	0.29%	55
2023 Q1	$8.05M	Hold	50,500	–	–	0.38%	48
2022 Q4	$8.16M	Hold	50,500	–	–	0.41%	48
2022 Q3	$6.78M	Hold	50,500	–	–	0.36%	54
2022 Q2	$7.74M	Hold	50,500	–	–	0.39%	52
2022 Q1	$8.19M	Hold	50,500	–	–	0.34%	54
2021 Q4	$6.84M	Hold	50,500	–	–	0.27%	65
2021 Q3	$5.45M	Hold	50,500	–	–	0.24%	73
2021 Q2	$5.69M	Hold	50,500	–	–	0.24%	73
2021 Q1	$5.46M	Hold	50,500	–	–	0.25%	75
2020 Q4	$5.41M	Hold	50,500	–	–	0.27%	71
2020 Q3	$4.42M	Hold	50,500	–	–	0.25%	76
2020 Q2	$4.96M	Hold	50,500	–	–	0.3%	69
2020 Q1	$3.85M	Hold	50,500	–	–	0.28%	74
2019 Q4	$4.47M	Hold	50,500	–	–	0.26%	78
2019 Q3	$3.82M	Buy	50,500 +32,500	+181%	+$2.23M	0.24%	84
2019 Q2	$1.31M	Buy	+18,000	New	+$1.41M	0.09%	129

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Cohen Klingenstein's ABBV Position: Q3 2026 in Review

Cohen Klingenstein held its AbbVie (ABBV) position steady in Q3 2026 at 18,000 shares worth $4.71M. The position accounts for 0.13% of the portfolio, ranked #73.

Cohen Klingenstein first reported a position in ABBV in Q2 2019 and has held it in 30 quarters since. The position peaked at $10M in Q3 2024. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Cohen Klingenstein held 18,000 shares of AbbVie worth $4.71M as of Q3 2026.
Cohen Klingenstein left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.13% of Cohen Klingenstein's portfolio in Q3 2026, its #73 holding.
Cohen Klingenstein first reported a position in AbbVie in Q2 2019 and has held it in 30 quarters since.
Cohen Klingenstein's AbbVie position peaked at $10M in Q3 2024.
2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cohen Klingenstein's 13F filing for Q3 2026, filed 15 Oct 2026.